REGULAR ARTICLES

Cell Research(2004) ; 14(2) : 141-147

ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells

Ze Jun TIAN ², Wei AN^1,*

¹Department of Cell Biology, Capital University of Medical Science, 10 Xitoutiao, You An Men Beijing 100054, China.
²Department of Cardiology, Second Hospital, Hebei Medical University, Shijiazhuang, China.

Received, June 16, 2003    Revised, Dec 12, 2003    Accepted, Jan 8, 2004

Correspondence: Wei AN 0086-10-63291921 (phone) 0086-10-63051130 (fax) anwei@cpums.edu.cn

Table of Contents Download as printable (PDF) file -951K Full Text (html)file Search Medline for articles by: Wei AN

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a recently characterized transcription factor which is essential to liver regeneration. We have previously reported that hepatic stimulator substance (HSS), a novel growth-promoting substance, phosphorylated the epidermal growth factor (EGF) receptors and activated downstream Ras-MAP kinase (extracellular signal-regulated kinases, ERK1/2) cascade. However, whether HSS signal is related to STAT3 pathway remains unclear. The present study is aiming to explore the regulatory effect of activation of ERK1/2 evoked by HSS on STAT3 phosphorylation and STAT3 signaling. Human hepatoma cell line HepG2 was stably transfected with HSS cDNA and HSS expression was measured by Northern blot. The results showed that the transfection of HSS into HepG2 resulted in remarkable increase in cellular proliferation as compared with the non-transfected cells, and it was further proved that the cellular proliferation in the HSS-transfected cells was related to ERK1/2 activation. Treatment of the cells with 50 ¦ÌM of PD98059, an ERK1/2 specific upstream inhibitor, resulted in ERK1/2 inactivation completely. Inhibition of ERK1/2 allowed the tyrosine of STAT3 to be phosphorylated in a dose-dependent manner to PD98059. Furthermore, transient transfection of STAT3 mutant (STAT3S727A) into HSS-bearing cells could remarkably reverse the inhibitory effect of ERK1/2 on STAT3 phosphorylation. Based upon these results, it is concluded that ERK1/2 negatively modulates STAT3 phosphorylation and this function is dependent on residual serine-727 (S727) of STAT3.

Keywords: hepatic stimulator substance, ERK1/2, STAT3, hepatocyte growth.